Development

INSIGHTS ON DRUG DEVELOPMENT

Biopharma Production And Quality Control With Electrophoresis
Discover how Kaneka Eurogentec, a leading provider of custom DNA synthesis and molecular biology services, enhanced their fragment analysis to achieve higher efficiency and accuracy in their workflows.
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
Evaluating Carryover When Using A TOC Analyzer
Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.

Unlocking Robust Separations For Modern Peptide Therapeutics
7/14/2026

As peptide therapeutics grow more complex, impurity profiling demands greater chromatographic confidence. See how robust reproducibility can support reliable GLP-1 receptor agonist analysis.
Using AI-Analysis And High-Content Screening To Improve Data Capturing
4/4/2025

Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.
Analyzing Biological Drug Effects In 3D
10/24/2025

Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.
Automated Bioburden Testing Solution
11/7/2025

Automation is transforming microbial quality control labs, boosting productivity, minimizing errors, and ensuring data integrity. Discover how digitalization is driving Pharma 4.0 and reshaping lab workflows.
API Solubility And Dissolution Enhancement Via Formulation
6/4/2025

Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.

Transforming Tissue Research With Open Multiplexing

Cell DIVE Multiplex Imaging Solution

What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?

Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
Quadrant 2™: Predictive Platform For Solubility And Bioavailability Enhancement

Poor solubility derails ~80% of molecules. Thermo Fisher Scientific's Quadrant 2 platform uses AI/ML to predict the right formulation strategy before lab work begins.
Leading The Way In Rapid Quantitation Of Host Cell DNA

Accurate, high-sensitivity quantitation of residual host cell DNA becomes faster and more consistent with integrated qPCR, automated prep, and broad assay coverage—helping streamline workflows.
A Technology-Driven CDMO Delivering Integrated End-To-End Services

Explore this interactive PDF with information about technologies & end-to-end integrated CDMO services provided by Adare Pharma Solutions.
Enhance Dissolution Rate With A Single High Performance Excipient

Enhance dissolution and lubrication in solid oral formulations. See how this approach supports poorly soluble actives, modern manufacturing methods, and consistent performance.